The Conclude Consultancy

On the 18th December 2019, just 3 months after the business was formally incorporated, TCC-CASEMIX Limited was notified that it had been selected as one of 15 innovative SME’s across the UK to participate in the Global Business Innovation Programme being run by UK R&I. The award is to participate in an innovation mission to South Korea in October 2020.

TCC-CASEMIX (TM) is already being seen as a compelling proposition, as it is the only company of the 15 selected, that has so far received a specific request to engage directly with a hospital and research team in the south of the country.

Dr Bacon comments: “Our extensive literature review identified that the planning of operating theatre sessions is as challenging in South Korea as it is here in the UK – so we share exactly the same needs: increasingly ageing populations making ever increasing demands on surgery, means that we have to learn to do far more with less. For surgery this means controlling the drivers that cause cancelled operations as much as those that cause theatres and their teams to be standing idle.”

TCC-CASEMIX Limited will be taking with them on this mission their highly innovative surgical procedure survey technology. This enables real-time data capture of procedure durations, critical to effective procedure planning. Earlier this month, the business also won an Innovation Support Grant part funded by the European Development Fund (and supported by Medilink East Midlands) to develop the technologies required. This has enabled the business to work with two of the UK’s most innovative technology companies to develop the solution. At the same time Dr Bacon and his team have been designing some of the hardware for the technology using latest 3D modelling and printing technologies.

TCC-CASEMIX Trademark is filed as: UK00003464512

Tweet This Tags: Operating theatre utilisation, TCC-CASEMIX (TM)